COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 243,903 units at $1.64 per unit for proceeds of $400,000. Additionally, incentive stock options and restricted share units are granted. Company focuses on cancer research and treatment -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
Onco-Innovations Limited appoints Dr. Dennis Hall, renowned chemist, to Scientific and Clinical Advisory Board. Dr. Hall brings expertise in boron chemistry, catalysis, and drug discovery to advance innovative oncology-focused therapies -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
Onco-Innovations partners with Redwood AI for drug development, leveraging AI-driven chemistry tools to enhance cancer therapy with PNKP Compound. Vancouver-based collaboration aims to improve research efficiency
